Article Versions Notes

Lastwika KJ, Wu W, Zhang Y, Ma N, Zečević M, Pipavath SNJ, Randolph TW, Houghton AM, Nair VS, Lampe PD, et al. Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment. Cancers. 2023; 15(13):3418. https://doi.org/10.3390/cancers15133418

Lastwika, Kristin J., Wei Wu, Yuzheng Zhang, Ningxin Ma, Mladen Zečević, Sudhakar N. J. Pipavath, Timothy W. Randolph, A. McGarry Houghton, Viswam S. Nair, Paul D. Lampe, and et al. 2023. "Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment" Cancers 15, no. 13: 3418. https://doi.org/10.3390/cancers15133418

Lastwika, K. J., Wu, W., Zhang, Y., Ma, N., Zečević, M., Pipavath, S. N. J., Randolph, T. W., Houghton, A. M., Nair, V. S., Lampe, P. D., & Kinahan, P. E. (2023). Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment. Cancers, 15(13), 3418. https://doi.org/10.3390/cancers15133418